Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study - Thuss-Patience, PC; Shah, MA; Ohtsu, A (Lancet Oncol, 2017)
et al.